Bexxar regimen

[BEX-ar REH-jih-men]
A combination of monoclonal antibodies used to treat certain types of non-Hodgkin's lymphoma. The monoclonal antibody tositumomab is given with iodine I 131 tositumomab (a form of tositumomab that has been chemically changed by adding radioactive iodine). Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.